SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Spero Therapeutics Q3 net loss widens on SP001 licensing payment

OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…

SPRO

Related stories